Objectives Pancreatic endocrine tumors (PETs) share numerous features with
gastrointestinal neuroendocrine (carcinoid) tumors. Targets of novel therapeutic strategies …

Background Kinases represent potential therapeutic targets in pancreatic endocrine tumours
(PETs). Patients and methods Thirty-five kinase genes were sequenced in 36 primary PETs …

OBJECTIVE: To review the available literature addressing the treatment of pancreatic
neuroendocrine tumors (PNETs) and carcinoid tumors. DATA SOURCES: Relevant literature …

Abstract Neuroendocrine (carcinoid) tumors (NETs) are endocrine neoplasms occurring
most frequently in gastrointestinal and bronchopulmonary (BP) systems. The majority of …

Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Well-differentiated neuroendocrine tumors (NETs) can be subdivided into carcinoid and
pancreatic NETs (panNETs). Recently, two therapies have been FDA approved for …

Simple Summary Pancreatic neuroendocrine tumors (pNETs) are rare, indolent cancers
whose causation is only partly understood. An increasing number of studies have uncovered …

Pancreatic endocrine tumors (PETs) are rare neoplasms which account for 1% to 2% of all
pancreatic malignancies. The diagnostic, grading and prognostic criteria for PETs have …

Current classifications of human gastroenteropancreatic neuroendocrine tumors (NETs) are
inconsistent and based upon histopathologic but not molecular features. We sought to …

Pancreatic neuroendocrine neoplasms (panNENs) are the second most common epithelial
tumors of the pancreas. Despite improvements in prognostic grading and staging systems, it …